MM
Mansi Mohapatra
About Mansi Mohapatra
Data last updated:
Mansi Mohapatra is a Director at Fronde Pharmaceuticals Private Limited (since 2024) and Director at Brcm Enterprises Private Limited (since 2019). The companies operate in Chemicals and Trading. The largest current company by reported revenue is Fronde Pharmaceuticals Private Limited at ₹11.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Jan 2024 | 2012 | ₹11.2 Lakh (FY 2025) | Active | |
| Director | 25 Sep 2019 | 2019 | Active |
Board colleagues of Mansi Mohapatra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anjan Kumar Behera | 05225660 | Fronde Pharmaceuticals Private Limited | Director |
| Sagar Kumar Nayak | 05204126 | Fronde Pharmaceuticals Private Limited | Managing Director |
| Biswadarsi Biswal | 08572548 | Brcm Enterprises Private Limited | Director |
| Chinmay Das | 06804639 | Brcm Enterprises Private Limited | Director |
| Rama Chandra Das | 06490679 | Brcm Enterprises Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mansi Mohapatra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mansi Mohapatra
Mansi Mohapatra currently holds 2 directorships: Fronde Pharmaceuticals Private Limited (Director, since 29 Jan 2024, revenue ₹11.2 Lakh (FY 2025)); Brcm Enterprises Private Limited (Director, since 25 Sep 2019).
Mansi Mohapatra was first appointed on 25 Sep 2019 as Director at Brcm Enterprises Private Limited. The most recent appointment on record is 29 Jan 2024 at Fronde Pharmaceuticals Private Limited.
The current boards of Mansi Mohapatra's companies include Anjan Kumar Behera (Fronde Pharmaceuticals Private Limited), Sagar Kumar Nayak (Fronde Pharmaceuticals Private Limited), Biswadarsi Biswal (Brcm Enterprises Private Limited), Chinmay Das (Brcm Enterprises Private Limited), Rama Chandra Das (Brcm Enterprises Private Limited).